Characteristics of drug-eluting stent platforms potentially influencing bifurcated lesion provisional stenting procedure

被引:18
|
作者
Burzotta, Francesco [1 ]
Mortier, Peter [2 ,3 ]
Trani, Carlo [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00141 Rome, Italy
[2] Ghent Univ Hosp, Inst Biomed Technol, bioMMeda, Ghent, Belgium
[3] FEops Bvba, Ghent, Belgium
关键词
bifurcated lesions; drug-eluting stent; provisional T-stenting; OPTICAL COHERENCE TOMOGRAPHY; NORDIC-BALTIC BIFURCATION; FRACTIONAL FLOW RESERVE; CORONARY STENT; 3-DIMENSIONAL ANALYSIS; BALLOON INFLATION; LEFT MAIN; COMPRESSION; DILATATION; EXPANSION;
D O I
10.4244/EIJV10I1A19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: We aimed to review the technical characteristics of DES platforms which have been documented to influence bifurcation stenting procedures conducted according to the provisional approach. Methods and results: DES platforms have remarkable technical differences (side cell diameter, shape, deformability, etc.). We reviewed the literature data and performed original virtual bench tests to highlight the characteristics of DES platforms which influence the following phases of bifurcation stenting conducted according to the provisional approach: stent implantation in the main vessel across side-branch take-off ("crossover" stenting), proximal optimisation technique, rewiring and kissing balloon inflation. Available data show that the response of different DES platforms to the various procedural steps of provisional stenting is different. Conclusions: When treating bifurcated lesions according to the provisional stenting approach, the search for an ideal matching between individual bifurcated anatomy and DES selection should take into account an articulated series of technical parameters.
引用
收藏
页码:124 / 132
页数:9
相关论文
共 50 条
  • [1] Results of provisional stenting for bifurcation lesion with drug-eluting stent
    Shirai, K.
    Costantini, C. C. O.
    Costantini, C. C. R.
    Yanagi, D. Y.
    Ike, A. I.
    Kubota, K. K.
    Takamiya, Y. T.
    Fukuda, Y. F.
    Zhang, B. Z.
    Saku, K. S.
    EUROPEAN HEART JOURNAL, 2007, 28 : 576 - 576
  • [2] Comparison of tissue characteristics in restenosis lesion between bioabsorbable polymer drug-eluting stent and durable polymer drug-eluting stent
    Kobayashi, N.
    Ito, Y.
    Hirano, K.
    Yamawaki, M.
    Araki, M.
    Sakai, T.
    Sakamoto, Y.
    Mori, S.
    Tsutsumi, M.
    Nauchi, M.
    Honda, Y.
    Makino, K.
    Shirai, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 526 - 526
  • [3] New drug-eluting stent platforms to prevent stent thrombosis
    Kereiakes, Dean J.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2007, 8 : S34 - S43
  • [4] Culotte bifurcation stenting with paclitaxel drug-eluting stent
    Mezzapelle, Giuseppe
    Baldari, Duccio
    Baglini, Roberto
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2007, 8 (01) : 63 - 66
  • [5] Direct Drug-Eluting Stenting to Reduce Stent Restenosis
    Remkes, Wouter S.
    Somi, Samer
    Roolvink, Vincent
    Rasoul, Saman
    Ottervanger, Jan Paul
    Gosselink, A. T. Marcel
    Hoorntje, Jan C. A.
    Dambrink, Jan-Henk E.
    de Boer, Menko-Jan
    Suryapranata, Harry
    van 't Hof, Arnoud W. J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (07) : 751 - 758
  • [6] Intravascular brachytherapy versus repeat drug-eluting stenting for the treatment of patients with drug-eluting stent restenosis
    Torquson, R
    Deible, R
    Smith, K
    Chu, WW
    Kent, KM
    Pichard, AD
    Suddath, WO
    Satler, LF
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 43B - 43B
  • [7] Re-stenting the stent: are drug-eluting stents the answer?
    Siegel, R. M.
    Bhaskaran, A.
    Barker, B.
    Yilma, Z.
    Shechter, J.
    Moon, K.
    Sargent, T.
    Vermillion, J.
    John, T.
    Romo, J. R.
    EUROPEAN HEART JOURNAL, 2007, 28 : 397 - 398
  • [8] A chicken in every pot and a drug-eluting stent in every lesion
    Teirstein, PS
    CIRCULATION, 2004, 109 (16) : 1906 - 1910
  • [9] Drug-Eluting Balloon Therapy for In-Stent Restenosis of Drug-Eluting Stents Choose and Prepare the Appropriate Lesion
    Brott, Brigitta C.
    Chatterjee, Arka
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10) : 979 - 980
  • [10] Mounting Evidence for Safety and Improved Outcomes of Drug-Eluting Stenting But Is It the Stent?
    King, Spencer B., III
    Hannan, Edward L.
    CIRCULATION, 2008, 118 (18) : 1783 - 1784